Ophthalmology and Therapy（眼科和治疗杂志）影响因子_期刊投稿发表

期刊简介

Aims and ScopeOphthalmology and Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad and will consider all scientifically sound research from preclinical, clinical (all phases), observational, real-world, and health outcomes research around the use of ophthalmological therapies, devices, and surgical techniques.The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/series, trial protocols and short communications such as commentaries and editorials. Ophthalmology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals.Rapid PublicationThe journal’s publication timelines aim for a rapid peer review of 2 weeks. If an article is accepted it will be published 3–4 weeks from acceptance. The rapid timelines are achieved through the combination of a dedicated in-house editorial team, who manage article workflow, and an extensive Editorial and Advisory Board who assist with peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model this allows for the rapid, efficient communication of the latest research and reviews, fostering the advancement of ophthalmic therapies.Open AccessAll articles published by Ophthalmology and Therapy are open access.Personal ServiceThe journal’s dedicated in-house editorial team offer a personal “concierge service” meaning authors will always have an editorial contact able to update them on the status of their manuscript. The editorial team check all manuscripts to ensure that articles conform to the most recent COPE, GPP and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research.Digital Features and Plain Language SummariesOphthalmology and Therapy offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by key summary points, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. If you consider that your paper would benefit from the inclusion of a digital feature, please let us know. Our editorial team are able to create high-quality slide decks and infographics in-house, and video abstracts through our partner Research Square, and would be happy to assist in any way we can. For further information about digital features, please contact the journal editor (see ‘Contact the Journal’ for email address), and see the ‘Guidelines for digital features and plain language summaries’ document under ‘Submission guidelines’. For examples of digital features please visit our showcase page https://springerhealthcare.com/expertise/publishing-digital-features/ Publication FeesUpon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €5250/$6000/£4300. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis.Peer Review ProcessUpon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.At least two extensive reviews are required to make the editorial decision, with the exception of some article types such as Commentaries, Editorials, and Letters which are generally reviewed by one member of the Editorial Board. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case-by-case basis and should be sent to the journal editor.PreprintsWe encourage posting of preprints of primary research manuscripts on preprint servers, authors’ or institutional websites, and open communications between researchers whether on community preprint servers or preprint commenting platforms. Posting of preprints is not considered prior publication and will not jeopardize consideration in our journals. Authors should disclose details of preprint posting during the submission process or at any other point during consideration in one of our journals. Once the manuscript is published, it is the author’s responsibility to ensure that the preprint record is updated with a publication reference, including the DOI and a URL link to the published version of the article on the journal website.Please follow the link for further information on preprint sharing:https://www.springer.com/gp/authors-editors/journal-author/journal-author-helpdesk/submission/1302#c16721550CopyrightOphthalmology and Therapy's content is published open access under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.ContactFor more information about the journal, including pre-submission enquiries, please contact christopher.vautrinot@springer.com.

目标和范围Ophthalmology and Therapy 是一份国际性、开放获取、同行评审（单盲）和快速出版的期刊。该杂志的范围很广，将考虑围绕眼科治疗、设备和手术技术的使用进行的临床前、临床（所有阶段）、观察性、现实世界和健康结果研究的所有科学合理的研究。该杂志是引起广大制药和医疗保健专业人士的兴趣，并发表原创研究、评论、病例报告/系列、试验方案和简短通讯，如评论和社论。眼科学和治疗将考虑所有科学合理的研究，无论是积极的、证实的还是消极的数据。欢迎提交与国际和/或特定国家/地区的受众相关的意见，这在研究人员试图针对更具体的患者群体时至关重要。这种包容性的方法使该期刊能够协助传播高质量的研究，而这些研究可能被其他期刊认为兴趣不足。快速出版该期刊的出版时间表旨在进行 2 周的快速同行评审。如果一篇文章被接受，它将在接受后 3-4 周内发表。快速的时间表是通过结合专门的内部编辑团队来实现的，他们管理文章工作流程，以及广泛的编辑和顾问委员会协助同行评审。这使得该期刊能够支持研究的快速传播，同时仍然提供强有力的同行评审。结合该杂志的开放获取模式，可以快速、高效地交流最新研究和评论，促进眼科治疗的进步。开放获取眼科和治疗发表的所有文章都是开放获取的。个人服务该杂志专门的内部编辑团队提供个人“礼宾服务”，这意味着作者将始终有一位编辑联系人能够向他们更新手稿的状态。编辑团队检查所有手稿，以确保文章符合最新的 COPE、GPP 和 ICMJE 出版指南。这支持发表符合道德和透明的研究。数字特征和通俗易懂的语言摘要Ophthalmology and Therapy 提供了一系列附加功能，旨在提高期刊内容的知名度、读者群和教育价值。每篇文章都附有关键摘要点，为广大读者提供了内容的高效概述。文章可能附有通俗易懂的语言摘要，以帮助对该领域有一定了解但不具备深入专业知识的读者理解文章的科学内容和总体含义。该期刊还提供了包括各种类型的数字功能的选项，包括动画摘要、视频摘要、幻灯片、音频幻灯片、教学视频、信息图表、播客和动画。所有附加功能均按照与文章本身相同的高标准进行同行评审。如果您认为您的论文将受益于包含数字功能，请告诉我们。我们的编辑团队能够通过我们的合作伙伴 Research Square 在内部创建高质量的幻灯片和信息图表以及视频摘要，并且很乐意尽我们所能提供帮助。有关数字特征的更多信息，请联系期刊编辑（请参阅“联系期刊”获取电子邮件地址），并参阅“提交指南”下的“数字特征和简明语言摘要指南”文件。有关数字功能的示例，请访问我们的展示页面 https://springerhealthcare.com/expertise/publishing-digital-features/ 出版费文章被接受后，作者将需要支付 5250 欧元/6000 美元/的强制性快速服务费4300英镑。该期刊将考虑发展中国家的费用折扣和减免，具体情况视具体情况而定。同行评审流程提交后，编辑团队会对稿件进行评估，以确保它们符合期刊的目标和范围，并进行检查对于抄袭。所有合适的提交都将接受全面的单盲同行评审。审稿人是根据他们在主题领域的相关专业知识和出版历史来选择的。该期刊拥有大量的编辑和顾问委员会成员，他们根据上述标准被选中协助同行评审。至少需要两次广泛的评审才能做出编辑决定，某些文章类型除外，例如作为评论、社论和信件，通常由编辑委员会的一名成员审阅。如果审稿人的建议存在冲突，将联系编辑委员会以获得进一步的建议和主持决定。然后手稿要么被接受，要么被拒绝，要么作者需要进行主要或次要的修改（可能需要处理审稿人的评论和编辑的评论）。重新提交修改后的手稿后，将与对审稿人评论的回复一起进行评估，如果修改充分，将被接受发表。被接受的手稿随后由制作团队进行编辑和排版，然后再在线发布。对同行评审后的决定提出的上诉将逐案考虑，并应发送给期刊编辑。预印本我们鼓励在预印本服务器、作者或机构网站上发布原始研究手稿的预印本，并开放研究人员之间的交流，无论是在社区预印本服务器或预印本评论平台上。预印本的发布不被视为先前出版，不会影响我们期刊的考虑。作者应在提交过程中或在我们的一种期刊中考虑期间的任何其他时间点披露预印本发布的详细信息。手稿发表后，作者有责任确保预印本记录更新出版参考，包括 DOI 和期刊网站上文章已发表版本的 URL 链接。请点击链接获取更多信息关于预印本共享：https://www.springer.com/gp/authors-editors/journal-author/journal-author-helpdesk/submission/1302#c16721550CopyrightOphthalmology and Therapy 的内容在知识共享署名-非商业许可下开放获取，它允许用户出于非商业目的阅读、复制、分发材料并制作衍生作品，只要引用原始作品的作者即可。作者将本文的任何商业用途的专有权转让给施普林格。有关知识共享署名-非商业许可的更多信息，请单击此处：http://creativecommons.org/licenses/by-nc/4.0.Contact有关该期刊的更多信息，包括提交前查询，请联系 christopher.vautrinot@斯普林格网站。

《Ophthalmology and Therapy》期刊已被查看：次